Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer

JERUSALEM, Jan. 20, 2022 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored research agree... Devices, Oncology Alpha Tau Medical, Alpha DaRT
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news